Clinical trial
Study on the Prescription of the Growth Hormone Saizen® for Adults in France and Follow-up of Treated Patients
NCT01080755 is registered in ClinicalTrials.gov with Merck KGaA, Darmstadt, Germany as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Study on the Prescription of the Growth Hormone Saizen® for Adults in France and Follow-up of Treated Patients
- Lead sponsor
- Merck KGaA, Darmstadt, Germany
- Phase
- Observational
- Overall status
- Completed
- Start date
- December 31, 2003
- Completion date
- September 30, 2012
- Enrollment
- 90 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
adult growth hormone deficiency